Bangalore University split into three universities

Bengaluru, May 29: The Karnataka government has requested the Civil Aviation Ministry to reduce the number of flights, emanating from Maharashtra, Tamil Nadu, Gujarat, Madhya Pradesh and Rajasthan to the state in view of the high number of Covid-19 Cases prevalent there.

In a clarification issued to the Media this evening, the Minister for Law and Parliamentary Affairs Mr J C Madhuswamy has said that Karnataka has not sought for imposing a ban on flights emanating from these places, as reported in some sections of the Media.

Karnataka has appealed to the Civil Aviation Ministry to take steps to lessen the air traffic to the State, with the sacred intention that there may not be adequate quarantine facilities if there is huge turnout at a short period, he added.

Bengaluru, Mar 12: Karnataka on Thursday confirmed another positive case of the deadly coronavirus, taking the total number of infected persons to five in the state.

According to a source from the State Health Department, the infected person, a 26-year-old patient had recently returned from Greece. He is currently under observation in an isolation ward in a city hospital.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.